Literature DB >> 34580750

Occlusal Trauma and Bisphosphonate-Related Osteonecrosis of the Jaw in Mice.

Yuichi Mine1, Karin Okuda2, Reina Yoshioka2, Yuuki Sasaki2, Tzu-Yu Peng3,4,5, Masato Kaku4, Yuji Yoshiko6, Hiroki Nikawa7, Takeshi Murayama2.   

Abstract

Osteonecrosis of the jaw (ONJ) is a serious adverse event that is associated with antiresorptive agents, and it manifests as bone exposure in the maxillofacial region. Previous clinical reports suggest that mechanical trauma would trigger ONJ in a manner that is similar to tooth extractions. To the best of our knowledge, there have been few detailed pathophysiological investigations of the mechanisms by which occlusal/mechanical trauma influences ONJ. Here, we developed a novel mouse model that exhibits ONJ following experimental hyperocclusion and nitrogen-containing bisphosphonate (N-BP) treatment. This in vivo model exhibited ONJ in alveolar bone, particularly in the mandible. Moreover, the experimental hyperocclusion induced remarkable alveolar bone resorption in both mouse mandible and maxilla, whereas N-BP treatment completely prevented alveolar bone resorption. In this study, we also modeled trauma by exposing clumps of mesenchymal stem cells (MSCs)/extracellular matrix complex to hydrostatic pressure in combination with N-BP. Hydrostatic pressure loading induced lactate dehydrogenase (LDH) release by calcified cell clumps that were differentiated from MSCs; this LDH release was enhanced by N-BP priming. These in vivo and in vitro models may contribute further insights into the effect of excessive mechanical loading on ONJ onset in patients with occlusal trauma.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  3D culture; Bisphosphonate; Hydrostatic pressure; Hyperocclusive state; Occlusal trauma; Osteonecrosis of the jaw

Mesh:

Substances:

Year:  2021        PMID: 34580750     DOI: 10.1007/s00223-021-00916-2

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  40 in total

1.  Bisphosphonates cause osteonecrosis of the jaw-like disease in mice.

Authors:  Yanming Bi; Yamei Gao; Driss Ehirchiou; Chunzhang Cao; Takashi Kikuiri; Anh Le; Songtao Shi; Li Zhang
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

2.  Bisphosphonate-induced osteonecrosis of the jaw in a rat model arises first after the bone has become exposed. No primary necrosis in unexposed bone.

Authors:  Jahan Abtahi; Fredrik Agholme; Olof Sandberg; Per Aspenberg
Journal:  J Oral Pathol Med       Date:  2012-01-23       Impact factor: 4.253

Review 3.  Role of occlusion in periodontal disease.

Authors:  Euloir Passanezi; Adriana Campos Passanezi Sant'Ana
Journal:  Periodontol 2000       Date:  2019-02       Impact factor: 7.589

Review 4.  Occlusal trauma and excessive occlusal forces: Narrative review, case definitions, and diagnostic considerations.

Authors:  Jingyuan Fan; Jack G Caton
Journal:  J Periodontol       Date:  2018-06       Impact factor: 6.993

5.  Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat.

Authors:  Tara L Aghaloo; Ben Kang; Eric C Sung; Michael Shoff; Matthew Ronconi; Jack E Gotcher; Olga Bezouglaia; Sarah M Dry; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2011-08       Impact factor: 6.741

6.  Possible pathogenic engagement of soluble Semaphorin 4D produced by γδT cells in medication-related osteonecrosis of the jaw (MRONJ).

Authors:  Alexandru Movila; Hani Mawardi; Kazuaki Nishimura; Tomomi Kiyama; Kenji Egashira; Jae-Young Kim; Alessandro Villa; Hajime Sasaki; Sook-Bin Woo; Toshihisa Kawai
Journal:  Biochem Biophys Res Commun       Date:  2016-10-05       Impact factor: 3.575

7.  Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice.

Authors:  Ben Kang; Simon Cheong; Thawinee Chaichanasakul; Olga Bezouglaia; Elisa Atti; Sarah M Dry; Flavia Q Pirih; Tara L Aghaloo; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2013-07       Impact factor: 6.741

Review 8.  Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents.

Authors:  Giuseppina Campisi; Stefano Fedele; Vittorio Fusco; Giuseppe Pizzo; Olga Di Fede; Alberto Bedogni
Journal:  Future Oncol       Date:  2014-02       Impact factor: 3.404

9.  Chemotherapeutic and antiresorptive combination therapy suppressed lymphangiogenesis and induced osteonecrosis of the jaw-like lesions in mice.

Authors:  Shinichiro Kuroshima; Junro Yamashita
Journal:  Bone       Date:  2013-05-28       Impact factor: 4.398

10.  American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; John Fantasia; Reginald Goodday; Tara Aghaloo; Bhoomi Mehrotra; Felice O'Ryan
Journal:  J Oral Maxillofac Surg       Date:  2014-05-05       Impact factor: 2.136

View more
  1 in total

Review 1.  Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ).

Authors:  Ran Yan; Ruixue Jiang; Longwei Hu; Yuwei Deng; Jin Wen; Xinquan Jiang
Journal:  Int J Oral Sci       Date:  2022-08-10       Impact factor: 24.897

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.